| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $871.7M | +41.9% |
| Cost of Revenue | $633.6M | +46.6% |
| Gross Profit | $238.2M | +30.6% |
| R&D Expense | $51.3M | +16.0% |
| SG&A Expense | $36.9M | +2.6% |
| Operating Income | $44.9M | +147.9% |
| Pre-tax Income | $53.9M | +114.7% |
| Income Tax | $9.8M | +248.9% |
| Net Income | $44.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $205.9M | +14.8% |
| Accounts Receivable | $119.8M | +56.8% |
| Current Assets | $345.6M | +27.9% |
| Total Assets | $576.2M | +14.1% |
| Current Liabilities | $81.5M | +29.9% |
| Total Liabilities | $90.7M | +20.5% |
| Stockholders' Equity | $485.6M | +13.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $63.6M | -7.5% |
| Capital Expenditures | $457K | -23.8% |
| Investing Cash Flow | -$36.8M | -7.2% |
| Financing Cash Flow | -$207K | +82.7% |
| Free Cash Flow | $63.2M | -7.4% |
| +97.9% |
| EPS (Basic) | $0.36 | +100.0% |
| EPS (Diluted) | $0.35 | +94.4% |